Detail of the clinical trial

Title of the trial A Multicenter Phase 3 Randomized, Open-Label Study of Bosutinib versus Imatinib in Adult Patients with Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
EudraCT number 2013-005101-31
Protocol number AV001
Sponsor Pfizer Inc, 235 East 42nd Street, New York, NY 10017, United States of America
Indications Hemato-oncology
Diagnosis chronic Myelogenous Leukemia
Population in clinical trial Adults (18-65 years)
Male
Female
Patients
Year of receiving the request to Institute (SÚKL) 2014
Date of approval by Institute (SÚKL) 3.10.2014
Date of approval by EC 24.9.2014
Date of initiation CT in ČR 27.1.2015
Date of ending CT in ČR 2.6.2020
Notice
Sites IV. Interní hematologická klinika,Fakultní Nemocnice Hradec Králové,Sokolská 581,Hradec Králové,500 05
Interní hematologická a onklogická klinika,Fakultní Nemocnice Brno,Jihlavská 20,Brno,625 00
I. Interní klinika ? klinika hematologie,Všeobecná Fakultní Nemocnice v Praze,U Nemocnice 2,Praha 2,128 08
Ústav hematologie a krevní transfuze,,U Nemocnice 2094/1,Praha 2,128 08

‹‹ Back to list